Related Experiment Videos
Cytokine pathways and joint inflammation in rheumatoid arthritis
1Department of Rheumatology, Guy's, King's, and St. Thomas' Hospitals School of Medicine, King's College, London, United Kingdom.
The New England Journal of Medicine
|March 22, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prostaglandin regulation of B-lymphocyte function.
Immunology today·2014
Systemic gene transfer of binding immunoglobulin protein (BiP) prevents disease progression in murine collagen-induced arthritis.
Clinical and experimental immunology·2014
Enhanced and persistent levels of interleukin (IL)-17⁺ CD4⁺ T cells and serum IL-17 in patients with early inflammatory arthritis.
Clinical and experimental immunology·2013
Defective CD8+CD28+ regulatory T cell suppressor function in rheumatoid arthritis is restored by tumour necrosis factor inhibitor therapy.
Clinical and experimental immunology·2013
Resolution-associated molecular patterns (RAMP): RAMParts defending immunological homeostasis?
Clinical and experimental immunology·2011
Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis.
The New England journal of medicine·2026
Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
The New England journal of medicine·2026
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk.
The New England journal of medicine·2026
Eplontersen for Transthyretin Amyloid Cardiomyopathy.
The New England journal of medicine·2026
Myeloproliferative Neoplasms.
The New England journal of medicine·2026
Cytokine-associated ROS and Ca2+ dysregulation in severe inflammatory cardiomyopathy.
Cardiovascular research·2026
Gradually Enlarging Nodular Pulmonary Amyloidosis Associated With Sjögren's Syndrome.
Respirology case reports·2026
A Case of Thyroid Dermopathy.
Cureus·2026
Immune dysregulation in osteoarthritis: Mechanisms, biomarkers, and therapeutic opportunities.
Journal of translational autoimmunity·2026